Get started
Author

Furkan Çakır

ORCID: 0000-0002-6925-1655
Observed ORCID: 0000-0002-6925-1655
OpenAlex ID: A5101895367
3‐Amino‐thiophene‐2‐carbohydrazide Derivatives as Anti Colon Cancer Agents: Synthesis, Characterization, In‐Silico and In‐Vitro Biological Activity Studies
2023 · Halil Şenol, Furkan Çakır · ChemistrySelect · 41
PDF
Synthesis and biological studies of acetophenone-based novel chalcone, semicarbazone, thiosemicarbazone and indolone derivatives: Structure-Activity relationship, molecular docking, molecular dynamics, and kinetic studies
2024 · Aynur Farzaliyeva, Halil Şenol, et al. · Journal of Molecular Structure · 40
Design, synthesis, and aldose reductase inhibition assessment of novel Quinazolin-4(3H)-one derivatives with 4-Bromo-2-Fluorobenzene functionality
2025 · Pelin Tokalı, Yeliz Demir, et al. · Bioorganic Chemistry · 38
Novel 4-((3-fluorobenzyl)oxy)benzohydrazide derivatives as promising anti-prostate cancer agents: Synthesis, characterization and in vitro & in silico biological activity studies
2024 · Furkan Çakır, Şeyma Ateşoğlu, et al. · Journal of Molecular Structure · 36
Aldose reductase inhibition properties of novel thiazolidin-2,4-diones: In vitro and in silico approach for the treatment of diabetes-related complications
2025 · Feyzi Sinan Tokalı, Yeliz Demir, et al. · Journal of Molecular Liquids · 35
Synthesis, characterization, In vitro and In silico investigations of novel 1,2,3-triazole substituted salicylic acid phenolic hydrazones hybrids targeting TGF-β2 expression in colorectal carcinoma
2025 · Ebru Nur Ay, Furkan Çakır, et al. · European Journal of Medicinal Chemistry · 21
Synthesis and evaluation of aldose reductase inhibition of new thiazolidine-quinazoline hybrids through in vitro and in silico approaches
2025 · Halil Şenol, Namık Kılınç, et al. · Computational Biology and Chemistry · 20
Design and synthesis of new thienopyrimidine derivatives as potential anticancer agents: From cytotoxicity screening to VEGFR inhibition modeling
2025 · Feyzi Sinan Tokalı, Halil Şenol, et al. · Journal of Molecular Structure · 17
Targeting Lung Cancer With Carvacrol‐Triazole‐Arylidene Hydrazide Hybrids: In Vitro and In Silico Cytotoxicity Assessments
2025 · Furkan Çakır, Şeyma Ateşoğlu, et al. · Chemistry & Biodiversity · 15
PDF
N-hexylsulfonyl indole based thiosemicarbazones as potent and selective ecto-5′-nucleotidase and NTPDase inhibitors
2025 · Zahra Batool, Shireen Mona Dutt, et al. · Bioorganic Chemistry · 14
2‐Propyl‐3‐Aminoquinazoline‐4(3 H )‐one Derivatives as Potential Androgen Receptor Inhibitors: Synthesis and Cytotoxicity Against PC3 Cell Line via In Vitro and In Silico Studies
2025 · Halil Şenol, Furkan Çakır, et al. · Archiv der Pharmazie · 14
Dual targeting of neuroblastoma and cholinesterase by morpholino/pyrrolidino-sulfonyl-indole thiosemicarbazones: Synthesis, characterization, enzyme inhibition, cytotoxicity, docking and dynamics studies
2025 · Zahra Batool, Gülbahar Özge Alim Toraman, et al. · Bioorganic Chemistry · 12
Novel thiazolidinedione hybrids as cholinesterase inhibitors and targeting neuroblastoma: design, synthesis, in vitro and in silico biological evaluations
2025 · Gurbet Çelik Turgut, Furkan Çakır, et al. · Bioorganic Chemistry · 12
Synthesis, Characterization, and In Vitro and In Silico Studies of Substituted‐Vanillin Hydrazones of Anthranilic Acid and Their Quinazolin‐4( 3H )‐One Analogues as Anti Breast Cancer Agents
2025 · Ebru Hacıosmanoğlu‐Aldoğan, Furkan Çakır, et al. · ChemistrySelect · 12
PDF
A series of 4-thiomorpholinophenyl-thiosemicarbazones as cholinesterase inhibitors with anti-neuroblastoma effects
2025 · Hina Aftab, Furkan Çakır, et al. · Bioorganic Chemistry · 11
Targeting Lung Cancer: Synthesis, Characterization, Enzyme Inhibition, and Antiproliferative Activity of 1 H ‐Benzo[ f ]chromen‐1‐One‐Thiosemicarbazones Supported by Molecular Docking
2025 · Shahid Raza, Muhammad Islam, et al. · Archiv der Pharmazie · 11
Photoorganocatalytic synthesis, characterization, crystal structure of two schiff bases and their In Vitro and In Silico evaluations as cholinesterase inhibitors
2025 · Gulu Abbasova, Ajdar Medjidov, et al. · Journal of Molecular Structure · 11
Synthesis, Characterization and In Vitro and In Silico Biological Evaluation of New Mannich-Based Rhodanine and Thiazolidine-2,4-dione Derivatives as Potential Anti-Lung-Cancer Agents
2025 · Halil Şenol, Feyzi Sinan Tokalı, et al. · Synlett · 10
Synthesis, human carbonic anhydrase I and II inhibition, and in silico studies of 2-ethoxy-6-formylphenyl [1,1′-biphenyl]-4-sulfonate derived thiosemicarbazones
2025 · Asad Rafiq, Muhammad Tayyab, et al. · Bioorganic Chemistry · 9
New quinazolinone-thiazolidinedione hybrids as selective anti-lung cancer agents and promising EGFR inhibitors
2026 · Pelin Tokalı, Ayşe Merve Şenol, et al. · Future Medicinal Chemistry · 8
Rational design of phenyl 2,4,5-trichlorobenzenesulfonate based thiosemicarbazones as α-glucosidase and α-amylase inhibitors: integrating enzymatic evaluation and molecular modeling
2026 · Faiqa Noreen, Magdi E. A. Zaki, et al. · RSC Advances · 7
PDF
Synthesis, antiproliferative activity targeting lung cancer and in silico studies of hydroxypiperidine substituted thiosemicarbazones
2025 · Hina Aftab, Muhammad Islam, et al. · Scientific Reports · 6
PDF
Design and synthesis of Polymethoxy Rhodanines as selective small-molecule candidates for breast cancers
2026 · Feyzi Sinan Tokalı, Gurbet Çelik Turgut, et al. · Journal of Molecular Structure · 5
Synthesis, Characterization, and Comprehensive In Vitro and In Silico Evaluation of the Anti‐Inflammatory Potential of Novel 1,2,3‐Triazole–Arylidenehydrazide/Thiazolidinone Hybrids
2025 · Nihan Aktaş Pepe, Furkan Çakır, et al. · Archiv der Pharmazie · 5
Synthesis, Characterization, and In Vitro and In Silico Biological Evaluation of Novel Polyphenols Bearing a Quinazolin-4(3H)-one Ring as Promising Anti-Prostate-Cancer Agents
2024 · Halil Şenol, Feyzi Sinan Tokalı, et al. · Synlett · 5
Works count: 30
Citation count: 419
H-index: 12
I10-index: 18
Year
Topic
Type